Movement Alert｜10x Genomics, Inc. Falls 5.04% in Regular Trading, Life Sciences Sector Broadly Under Pressure Ahead of Earnings

Market Focus08-07 00:23

On August 6, 10x Genomics, Inc. fell 5.04% in regular trading, trading at $45.175/share with turnover of $31.53 million. The decline came amid broad selling pressure across the Life Sciences Tools & Services sector, with peer Illumina notably declining 5.67% on the same day.

The selloff occurred ahead of the company's Q2 earnings report scheduled for release after market close. Market consensus expected quarterly revenue of approximately $147 million, representing 5.28% year-over-year growth, with adjusted EPS of -$0.24, a 34.45% improvement from the prior year. The company had previously beaten Q1 estimates with EPS of -$0.10 versus the -$0.30 consensus and revenue of $150.8 million above the $146.4 million estimate.

Among sector peers, Thermo Fisher Scientific fell 0.51%, Danaher declined 0.97%, IQVIA dropped 2.79%, and Waters fell 1.39%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120100434?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 00:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120100434","market":"hk","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Falls 5.04% in Regular Trading, Life Sciences Sector Broadly Under Pressure Ahead of Earnings","media":"Market Focus","content":"<p><p>On August 6, 10x Genomics, Inc. fell 5.04% in regular trading, trading at $45.175/share with turnover of $31.53 million. The decline came amid broad selling pressure across the Life Sciences Tools & Services sector, with peer Illumina notably declining 5.67% on the same day.</p><p>The selloff occurred ahead of the company's Q2 earnings report scheduled for release after market close. Market consensus expected quarterly revenue of approximately $147 million, representing 5.28% year-over-year growth, with adjusted EPS of -$0.24, a 34.45% improvement from the prior year. The company had previously beaten Q1 estimates with EPS of -$0.10 versus the -$0.30 consensus and revenue of $150.8 million above the $146.4 million estimate.</p><p>Among sector peers, Thermo Fisher Scientific fell 0.51%, Danaher declined 0.97%, IQVIA dropped 2.79%, and Waters fell 1.39%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Falls 5.04% in Regular Trading, Life Sciences Sector Broadly Under Pressure Ahead of Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Falls 5.04% in Regular Trading, Life Sciences Sector Broadly Under Pressure Ahead of Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-07 00:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 6, 10x Genomics, Inc. fell 5.04% in regular trading, trading at $45.175/share with turnover of $31.53 million. The decline came amid broad selling pressure across the Life Sciences Tools & Services sector, with peer Illumina notably declining 5.67% on the same day.</p><p>The selloff occurred ahead of the company's Q2 earnings report scheduled for release after market close. Market consensus expected quarterly revenue of approximately $147 million, representing 5.28% year-over-year growth, with adjusted EPS of -$0.24, a 34.45% improvement from the prior year. The company had previously beaten Q1 estimates with EPS of -$0.10 versus the -$0.30 consensus and revenue of $150.8 million above the $146.4 million estimate.</p><p>Among sector peers, Thermo Fisher Scientific fell 0.51%, Danaher declined 0.97%, IQVIA dropped 2.79%, and Waters fell 1.39%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1120100434","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120100434","pubTimestamp":1786033391,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 6, 10x Genomics, Inc. fell 5.04% in regular trading, trading at $45.175/share with turnover of $31.53 million. The decline came amid broad selling pressure across the Life Sciences Tools &...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易中下跌 5.04%，生命科学板块在财报公布前普遍面临压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On August 6, 10x Genomics, Inc. fell 5.04% in regular trading, trading at $45.175/share with turnover of $31.53 million. The decline came amid broad selling pressure across the Life Sciences Tools & Services sector, with peer Illumina notably declining 5.67% on the same day.The selloff occurred ahead of the company's Q2 earnings report scheduled for release after market close. Market consensus expected quarterly revenue of approximately $147 million, representing 5.28% year-over-year growth, with adjusted EPS of -$0.24, a 34.45% improvement from the prior year. The company had previously beaten Q1 estimates with EPS of -$0.10 versus the -$0.30 consensus and revenue of $150.8 million above the $146.4 million estimate.Among sector peers, Thermo Fisher Scientific fell 0.51%, Danaher declined 0.97%, IQVIA dropped 2.79%, and Waters fell 1.39%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120100434","isCrawlerRequest":true}